🔗 Share this article

A shadow economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Several professionals said the popularity for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

According to the social media company, the service has taken down problematic content and banned related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Within these groups, posts show black plastic parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious medical dangers”.